Download PDF
Semin Reprod Med 2018; 36(02): 123-135
DOI: 10.1055/s-0038-1676089
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Interstitial Cystitis/Bladder Pain Syndrome

Ioana Marcu
1   Department of Obstetrics, Gynecology, and Women's Health, St. Louis University, St. Louis, Missouri
,
E. Cristian Campian
1   Department of Obstetrics, Gynecology, and Women's Health, St. Louis University, St. Louis, Missouri
,
Frank F. Tu
2   Department of Obstetrics and Gynecology, Pritzker School of Medicine, University of Chicago, Evanston, Illinois
› Author Affiliations
Further Information

Publication History

Publication Date:
19 December 2018 (online)

   Permissions and Reprints

Abstract

Interstitial cystitis/bladder pain syndrome is an uncommon but potentially devastating pelvic pain disorder affecting both women and men. This condition is often confusable and comorbid with other pelvic pain disorders. Although our understanding of the underlying pathophysiology is growing, the exact longitudinal course by which peripheral and central aberrations involving the bladder mucosa, peripheral inflammation, and central dysregulation of bladder sensitivity create painful bladder symptoms remains an area in need of further study. Only a limited number of drugs have been approved for treatment by the Food and Drug Administration, and overall durable efficacy of the many treatments reviewed in recent American Urological Association guidelines remains suboptimal, making awareness, early diagnosis, and use of effective treatments early in the disease course, where neural changes may still be reversible, imperative.

Keywords

chronic overlapping pain conditions - cross-organ sensitization - glycosaminoglycan layer
 

  • References

  • 1 McLennan MT. Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation. Obstet Gynecol Clin North Am 2014; 41 (03) 385-395
    CrossrefPubMedGoogle Scholar
  • 2 Davis NF, Gnanappiragasam S, Thornhill JA. Interstitial cystitis/painful bladder syndrome: the influence of modern diagnostic criteria on epidemiology and on Internet search activity by the public. Transl Androl Urol 2015; 4 (05) 506-511
    PubMedGoogle Scholar
  • 3 Jones CA, Nyberg L. Epidemiology of interstitial cystitis. Urology 1997; 49 (5A, Suppl): 2-9
    PubMedGoogle Scholar
  • 4 Hanno PM. Re-imagining interstitial cystitis. Urol Clin North Am 2008; 35 (01) 91-99 , vii
    CrossrefPubMedGoogle Scholar
  • 5 Clemens JQ, Link CL, Eggers PW, Kusek JW, Nyberg Jr LM, McKinlay JB. ; BACH Survey Investigators. Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol 2007; 177 (04) 1390-1394
    CrossrefPubMedGoogle Scholar
  • 6 Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol 2014; 175: 30-37
    CrossrefPubMedGoogle Scholar
  • 7 Suskind AM, Berry SH, Ewing BA, Elliott MN, Suttorp MJ, Clemens JQ. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. J Urol 2013; 189 (01) 141-145
    CrossrefPubMedGoogle Scholar
  • 8 Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 2001; 165 (03) 842-845
    CrossrefPubMedGoogle Scholar
  • 9 Berry SH, Bogart LM, Pham C. , et al. Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol 2010; 183 (05) 1848-1852
    CrossrefPubMedGoogle Scholar
  • 10 Hanno PM, Burks DA, Clemens JQ. , et al; Interstitial Cystitis Guidelines Panel of the American Urological Association Education and Research, Inc. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2011; 185 (06) 2162-2170
    CrossrefPubMedGoogle Scholar
  • 11 van de Merwe JP, Nordling J, Bouchelouche P. , et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 2008; 53 (01) 60-67
    CrossrefPubMedGoogle Scholar
  • 12 Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol 1988; 140 (01) 203-206
    CrossrefPubMedGoogle Scholar
  • 13 Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg Jr L. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999; 161 (02) 553-557
    CrossrefPubMedGoogle Scholar
  • 14 Simon LJ, Landis JR, Erickson DR, Nyberg LM. The Interstitial Cystitis Data Base Study: concepts and preliminary baseline descriptive statistics. Urology 1997; 49 (5A, Suppl): 64-75
    CrossrefPubMedGoogle Scholar
  • 15 Clemens JQ, Mullins C, Kusek JW. , et al; MAPP Research Network Study Group. The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol 2014; 14: 57
    CrossrefPubMedGoogle Scholar
  • 16 Vij M, Srikrishna S, Cardozo L. Interstitial cystitis: diagnosis and management. Eur J Obstet Gynecol Reprod Biol 2012; 161 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 17 Parsons CL. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 2007; 69 (4, Suppl): 9-16
    CrossrefPubMedGoogle Scholar
  • 18 Hurst RE, Moldwin RM, Mulholland SG. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology 2007; 69 (4, Suppl): 17-23
    CrossrefPubMedGoogle Scholar
  • 19 Cole EE, Scarpero HM, Dmochowski RR. Are patient symptoms predictive of the diagnostic and/or therapeutic value of hydrodistention?. Neurourol Urodyn 2005; 24 (07) 638-642
    CrossrefPubMedGoogle Scholar
  • 20 Lamale LM, Lutgendorf SK, Hoffman AN, Kreder KJ. Symptoms and cystoscopic findings in patients with untreated interstitial cystitis. Urology 2006; 67 (02) 242-245
    CrossrefPubMedGoogle Scholar
  • 21 Aihara K, Hirayama A, Tanaka N, Fujimoto K, Yoshida K, Hirao Y. Hydrodistension under local anesthesia for patients with suspected painful bladder syndrome/interstitial cystitis: safety, diagnostic potential and therapeutic efficacy. Int J Urol 2009; 16 (12) 947-952
    CrossrefPubMedGoogle Scholar
  • 22 Fall M, Peeker R. Classic interstitial cystitis: unrelated to BPS. Curr Bladder Dysfunct Rep 2015; 10 (01) 95-102
    CrossrefPubMedGoogle Scholar
  • 23 Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and nonulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology 2011; 78 (02) 301-308
    CrossrefPubMedGoogle Scholar
  • 24 Messing E, Pauk D, Schaeffer A. , et al. Associations among cystoscopic findings and symptoms and physical examination findings in women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology 1997; 49 (5A, Suppl): 81-85
    CrossrefPubMedGoogle Scholar
  • 25 Wennevik GE, Meijlink JM, Hanno P, Nordling J. The role of glomerulations in bladder pain syndrome: a review. J Urol 2016; 195 (01) 19-25
    CrossrefPubMedGoogle Scholar
  • 26 Waxman JA, Sulak PJ, Kuehl TJ. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998; 160 (05) 1663-1667
    CrossrefPubMedGoogle Scholar
  • 27 Chung MK, Butrick CW, Chung CW. The overlap of interstitial cystitis/painful bladder syndrome and overactive bladder. JSLS 2010; 14 (01) 83-90
    CrossrefPubMedGoogle Scholar
  • 28 Erickson DR, Tomaszewski JE, Kunselman AR. , et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis?. J Urol 2005; 173 (01) 93-97
    PubMedGoogle Scholar
  • 29 Sastry DN, Hunter KM, Whitmore KE. Urodynamic testing and interstitial cystitis/painful bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2010; 21 (02) 157-161
    CrossrefPubMedGoogle Scholar
  • 30 Doiron RC, Tolls V, Irvine-Bird K, Kelly K-L, Nickel JC. Clinical phenotyping does not differentiate Hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol 2016; 196 (04) 1136-1140
    CrossrefPubMedGoogle Scholar
  • 31 Warren JW, Brown V, Jacobs S, Horne L, Langenberg P, Greenberg P. Urinary tract infection and inflammation at onset of interstitial cystitis/painful bladder syndrome. Urology 2008; 71 (06) 1085-1090
    CrossrefPubMedGoogle Scholar
  • 32 Warren JW, Howard FM, Cross RK. , et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology 2009; 73 (01) 52-57
    CrossrefPubMedGoogle Scholar
  • 33 Dell JR, Mokrzycki ML, Jayne CJ. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Eur J Obstet Gynecol Reprod Biol 2009; 144 (02) 105-109
    CrossrefPubMedGoogle Scholar
  • 34 Peeker R, Enerbäck L, Fall M, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol 2000; 163 (03) 1009-1015
    CrossrefPubMedGoogle Scholar
  • 35 Dundore PA, Schwartz AM, Semerjian H. Mast cell counts are not useful in the diagnosis of nonulcerative interstitial cystitis. J Urol 1996; 155 (03) 885-887
    CrossrefPubMedGoogle Scholar
  • 36 Tomaszewski JE, Landis JR, Russack V. , et al; Interstitial Cystitis Database Study Group. Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study. Urology 2001; 57 (6, Suppl 1): 67-81
    CrossrefPubMedGoogle Scholar
  • 37 Theoharides TC, Kempuraj D, Sant GR. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 2001; 57 (6, Suppl 1): 47-55
    CrossrefPubMedGoogle Scholar
  • 38 Imamov O, Yakimchuk K, Morani A. , et al. Estrogen receptor beta-deficient female mice develop a bladder phenotype resembling human interstitial cystitis. Proc Natl Acad Sci U S A 2007; 104 (23) 9806-9809
    CrossrefPubMedGoogle Scholar
  • 39 Pang X, Marchand J, Sant GR, Kream RM, Theoharides TC. Increased number of substance P positive nerve fibres in interstitial cystitis. Br J Urol 1995; 75 (06) 744-750
    CrossrefPubMedGoogle Scholar
  • 40 Theoharides TC, Pang X, Letourneau R, Sant GR. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann N Y Acad Sci 1998; 840: 619-634
    CrossrefPubMedGoogle Scholar
  • 41 Bjorling DE, Wang ZY. Estrogen and neuroinflammation. Urology 2001; 57 (6, Suppl 1): 40-46
    PubMedGoogle Scholar
  • 42 Keay SK, Zhang CO, Shoenfelt J. , et al. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 2001; 57 (6, Suppl 1): 9-14
    CrossrefPubMedGoogle Scholar
  • 43 Argade S, Chen T, Shaw T. , et al. An evaluation of Tamm-Horsfall protein glycans in kidney stone formers using novel techniques. Urolithiasis 2015; 43 (04) 303-312
    CrossrefPubMedGoogle Scholar
  • 44 Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol 2007; 51 (03) 803-808 , discussion 809
    CrossrefPubMedGoogle Scholar
  • 45 Leppilahti M, Tammela TLJ, Huhtala H, Auvinen A. Prevalence of symptoms related to interstitial cystitis in women: a population based study in Finland. J Urol 2002; 168 (01) 139-143
    CrossrefPubMedGoogle Scholar
  • 46 Kennedy CM, Bradley CS, Galask RP, Nygaard IE. Risk factors for painful bladder syndrome in women seeking gynecologic care. Int Urogynecol J Pelvic Floor Dysfunct 2006; 17 (01) 73-78
    CrossrefPubMedGoogle Scholar
  • 47 Tettamanti G, Nyman-Iliadou A, Pedersen NL, Bellocco R, Milsom I, Altman D. Influence of smoking, coffee, and tea consumption on bladder pain syndrome in female twins. Urology 2011; 77 (06) 1313-1317
    CrossrefPubMedGoogle Scholar
  • 48 Pons M, Marin-Castaño ME. Nicotine increases the VEGF/PEDF ratio in retinal pigment epithelium: a possible mechanism for CNV in passive smokers with AMD. Invest Ophthalmol Vis Sci 2011; 52 (06) 3842-3853
    CrossrefPubMedGoogle Scholar
  • 49 Lee J, Cooke JP. Nicotine and pathological angiogenesis. Life Sci 2012; 91 (21-22): 1058-1064
    CrossrefPubMedGoogle Scholar
  • 50 Heeschen C, Jang JJ, Weis M. , et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001; 7 (07) 833-839
    CrossrefPubMedGoogle Scholar
  • 51 Dulak J, Józkowicz A, Dembinska-Kiec A. , et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000; 20 (03) 659-666
    CrossrefPubMedGoogle Scholar
  • 52 Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T. Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol 2004; 172 (03) 945-948
    CrossrefPubMedGoogle Scholar
  • 53 Kiuchi H, Tsujimura A, Takao T. , et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome/interstitial cystitis: its association with pain severity and glomerulations. BJU Int 2009; 104 (06) 826-831 , discussion 831
    CrossrefPubMedGoogle Scholar
  • 54 Ueda T, Tamaki M, Ogawa O, Yoshimura N. Over expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in patients with interstitial cystitis and bladder carcinoma. J Urol 2002; 167 (01) 347-351
    CrossrefPubMedGoogle Scholar
  • 55 Chao W, Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 1993; 292 (Pt 3) 617-629
    CrossrefPubMedGoogle Scholar
  • 56 Yost CC, Weyrich AS, Zimmerman GA. The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses. Biochimie 2010; 92 (06) 692-697
    CrossrefPubMedGoogle Scholar
  • 57 McIntyre TM, Zimmerman GA, Satoh K, Prescott SM. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest 1985; 76 (01) 271-280
    CrossrefPubMedGoogle Scholar
  • 58 Nilsson G, Metcalfe DD, Taub DD. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology 2000; 99 (02) 314-319
    PubMedGoogle Scholar
  • 59 Marentette JO, McHowat J. Redistribution of calcium-independent phospholipase A2 isoforms in IC/BPS urothelial cells. Arch Physiol 2015; 2 (01) 3
    PubMedGoogle Scholar
  • 60 Marentette J, Kolar G, McHowat J. Increased susceptibility to bladder inflammation in smokers: targeting the PAF-PAF receptor interaction to manage inflammatory cell recruitment. Physiol Rep 2015; 3 (12) e12641
    CrossrefPubMedGoogle Scholar
  • 61 Parker KS, Crowley JR, Stephens-Shields AJ. , et al. Urinary metabolomics identifies a molecular correlate of interstitial cystitis/bladder pain syndrome in a multidisciplinary approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort. EBioMedicine 2016; 7: 167-174
    CrossrefPubMedGoogle Scholar
  • 62 Sculptoreanu A, de Groat WC, Buffington CAT, Birder LA. Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol 2005; 193 (02) 437-443
    CrossrefPubMedGoogle Scholar
  • 63 Huang L, Kutch JJ, Ellingson BM. , et al. Brain white matter changes associated with urological chronic pelvic pain syndrome: multisite neuroimaging from a MAPP case-control study. Pain 2016; 157 (12) 2782-2791
    CrossrefPubMedGoogle Scholar
  • 64 Nazif O, Teichman JMH, Gebhart GF. Neural upregulation in interstitial cystitis. Urology 2007; 69 (04, Suppl): 24-33
    CrossrefPubMedGoogle Scholar
  • 65 Wesselmann U. Neurogenic inflammation and chronic pelvic pain. World J Urol 2001; 19 (03) 180-185
    CrossrefPubMedGoogle Scholar
  • 66 Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL. Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 1997; 79 (04) 572-577
    CrossrefPubMedGoogle Scholar
  • 67 Vizzard MA. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp Neurol 2000; 161 (01) 273-284
    CrossrefPubMedGoogle Scholar
  • 68 Cervero F. Sensory innervation of the viscera: peripheral basis of visceral pain. Physiol Rev 1994; 74 (01) 95-138
    CrossrefPubMedGoogle Scholar
  • 69 Dubner R, Ruda MA. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci 1992; 15 (03) 96-103
    CrossrefPubMedGoogle Scholar
  • 70 Hellman KM, Datta A, Steiner ND. , et al. Identification of experimental bladder sensitivity among dysmenorrhea sufferers. Am J Obstet Gynecol 2018; 219 (01) 84.e1-84.e8
    CrossrefPubMedGoogle Scholar
  • 71 Lai HH, North CS, Andriole GL, Sayuk GS, Hong BA. Polysymptomatic, polysyndromic presentation of patients with urological chronic pelvic pain syndrome. J Urol 2012; 187 (06) 2106-2112
    CrossrefPubMedGoogle Scholar
  • 72 Berkley KJ. A life of pelvic pain. Physiol Behav 2005; 86 (03) 272-280
    CrossrefPubMedGoogle Scholar
  • 73 Ustinova EE, Fraser MO, Pezzone MA. Cross-talk and sensitization of bladder afferent nerves. Neurourol Urodyn 2010; 29 (01) 77-81
    CrossrefPubMedGoogle Scholar
  • 74 Malykhina AP. Neural mechanisms of pelvic organ cross-sensitization. Neuroscience 2007; 149 (03) 660-672
    CrossrefPubMedGoogle Scholar
  • 75 Tu FF, Kane JN, Hellman KM. Noninvasive experimental bladder pain assessment in painful bladder syndrome. BJOG 2017; 124 (02) 283-291
    CrossrefPubMedGoogle Scholar
  • 76 Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004; 27 (08) 729-737
    CrossrefPubMedGoogle Scholar
  • 77 Kleinhans NM, Yang CC, Strachan ED, Buchwald DS, Maravilla KR. Alterations in connectivity on functional magnetic resonance imaging with provocation of lower urinary tract symptoms: a MAPP research network feasibility study of urological chronic pelvic pain syndromes. J Urol 2016; 195 (03) 639-645
    CrossrefPubMedGoogle Scholar
  • 78 Harper DE, Ichesco E, Schrepf A. , et al; MAPP Research Network. Relationships between brain metabolite levels, functional connectivity, and negative mood in urologic chronic pelvic pain syndrome patients compared to controls: a MAPP research network study. Neuroimage Clin 2017; 17: 570-578
    PubMedGoogle Scholar
  • 79 Hanno PM. Interstitial cystitis-epidemiology, diagnostic criteria, clinical markers. Rev Urol 2002; 4 (Suppl 1): S3-S8
    PubMedGoogle Scholar
  • 80 Ottem DP, Teichman JMH. What is the value of cystoscopy with hydrodistension for interstitial cystitis?. Urology 2005; 66 (03) 494-499
    CrossrefPubMedGoogle Scholar
  • 81 Teichman JMH, Parsons CL. Contemporary clinical presentation of interstitial cystitis. Urology 2007; 69 (4, Suppl): 41-47
    CrossrefPubMedGoogle Scholar
  • 82 Parsons CL. Interstitial cystitis: clinical manifestations and diagnostic criteria in over 200 cases. Neurourol Urodyn 1990; 9 (03) 241-250
    CrossrefPubMedGoogle Scholar
  • 83 Ito T, Ueda T, Honma Y, Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int J Urol 2007; 14 (12) 1068-1070
    CrossrefPubMedGoogle Scholar
  • 84 Close CE, Carr MC, Burns MW. , et al. Interstitial cystitis in children. J Urol 1996; 156 (2, Pt 2): 860-862
    CrossrefPubMedGoogle Scholar
  • 85 Alagiri M, Chottiner S, Ratner V, Slade D, Hanno PM. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49 (5A, Suppl): 52-57
    CrossrefPubMedGoogle Scholar
  • 86 Koziol JA, Clark DC, Gittes RF, Tan EM. The natural history of interstitial cystitis: a survey of 374 patients. J Urol 1993; 149 (03) 465-469
    CrossrefPubMedGoogle Scholar
  • 87 Driscoll A, Teichman JM. How do patients with interstitial cystitis present?. J Urol 2001; 166 (06) 2118-2120
    CrossrefPubMedGoogle Scholar
  • 88 Parsons CL. Interstitial cystitis: epidemiology and clinical presentation. Clin Obstet Gynecol 2002; 45 (01) 242-249
    CrossrefPubMedGoogle Scholar
  • 89 Parsons CL, Bullen M, Kahn BS, Stanford EJ, Willems JJ. Gynecologic presentation of interstitial cystitis as detected by intravesical potassium sensitivity. Obstet Gynecol 2001; 98 (01) 127-132
    PubMedGoogle Scholar
  • 90 Lai HH, North CS, Andriole GL. , et al. Urological symptoms in a subset of patients with urological chronic pelvic pain syndrome and a polysymptomatic, polysyndromic pattern of presentation. J Urol 2014; 191 (06) 1802-1807
    CrossrefPubMedGoogle Scholar
  • 91 Kim SH, Oh SA, Oh SJ. Voiding diary might serve as a useful tool to understand differences between bladder pain syndrome/interstitial cystitis and overactive bladder. Int J Urol 2014; 21 (02) 179-183
    CrossrefPubMedGoogle Scholar
  • 92 Shorter B, Lesser M, Moldwin RM, Kushner L. Effect of comestibles on symptoms of interstitial cystitis. J Urol 2007; 178 (01) 145-152
    CrossrefPubMedGoogle Scholar
  • 93 Herati AS, Shorter B, Srinivasan AK. , et al. Effects of foods and beverages on the symptoms of chronic prostatitis/chronic pelvic pain syndrome. Urology 2013; 82 (06) 1376-1380
    CrossrefPubMedGoogle Scholar
  • 94 Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int 2012; 109 (11) 1584-1591
    CrossrefPubMedGoogle Scholar
  • 95 Bogart LM, Berry SH, Clemens JQ. Symptoms of interstitial cystitis, painful bladder syndrome and similar diseases in women: a systematic review. J Urol 2007; 177 (02) 450-456
    PubMedGoogle Scholar
  • 96 Koziol JA. Epidemiology of interstitial cystitis. Urol Clin North Am 1994; 21 (01) 7-20
    PubMedGoogle Scholar
  • 97 Rudick CN, Chen MC, Mongiu AK, Klumpp DJ. Organ cross talk modulates pelvic pain. Am J Physiol Regul Integr Comp Physiol 2007; 293 (03) R1191-R1198
    CrossrefPubMedGoogle Scholar
  • 98 Christianson JA, Liang R, Ustinova EE, Davis BM, Fraser MO, Pezzone MA. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain 2007; 128 (03) 235-243
    CrossrefPubMedGoogle Scholar
  • 99 Bernie JE, Hagey S, Albo ME, Parsons CL. The intravesical potassium sensitivity test and urodynamics: implications in a large cohort of patients with lower urinary tract symptoms. J Urol 2001; 166 (01) 158-161
    CrossrefPubMedGoogle Scholar
  • 100 Parsons CL, Dell J, Stanford EJ. , et al. Increased prevalence of interstitial cystitis: previously unrecognized urologic and gynecologic cases identified using a new symptom questionnaire and intravesical potassium sensitivity. Urology 2002; 60 (04) 573-578
    CrossrefPubMedGoogle Scholar
  • 101 Sutcliffe S, Jemielita T, Lai HH. , et al; MAPP Research Network. A case-crossover study of urological chronic pelvic pain syndrome flare triggers in the MAPP research network. J Urol 2018; 199 (05) 1245-1251
    CrossrefPubMedGoogle Scholar
  • 102 Henderson LJ. Diagnosis, treatment, and lifestyle changes of interstitial cystitis. AORN J 2000; 71 (03) 525-530 , 533–536, 538
    CrossrefPubMedGoogle Scholar
  • 103 Nickel JC, Tripp DA, Pontari M. , et al. Psychosocial phenotyping in women with interstitial cystitis/painful bladder syndrome: a case control study. J Urol 2010; 183 (01) 167-172
    CrossrefPubMedGoogle Scholar
  • 104 Clemens JQ, Calhoun EA, Litwin MS. , et al; Urologic Pelvic Pain Collaborative Research Network. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology 2009; 74 (05) 983-987 , quiz 987.e1–987.e3
    CrossrefPubMedGoogle Scholar
  • 105 Lai HH, North CS, Andriole GL. , et al. Urological symptoms in a subset of patients with urological chronic pelvic pain syndrome and a polysymptomatic, polysyndromic pattern of presentation. J Urol 2014; 191 (06) 1802-1807
    CrossrefPubMedGoogle Scholar
  • 106 Nickel JC, Shoskes D, Irvine-Bird K. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management. J Urol 2009; 182 (01) 155-160
    CrossrefPubMedGoogle Scholar
  • 107 Erickson DR, Simon LJ, Belchis DA. Relationships between bladder inflammation and other clinical features in interstitial cystitis. Urology 1994; 44 (05) 655-659
    CrossrefPubMedGoogle Scholar
  • 108 Al-Hadithi H, Tincello DG, Vince GS, Richmond DH. Leukocyte populations in interstitial cystitis and idiopathic reduced bladder storage. Urology 2002; 59 (06) 851-855
    CrossrefPubMedGoogle Scholar
  • 109 Richter B, Roslind A, Hesse U. , et al. YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome/interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis. Histopathology 2010; 57 (03) 371-383
    CrossrefPubMedGoogle Scholar
  • 110 Rais-Bahrami S, Friedlander JI, Herati AS, Sadek MA, Ruzimovsky M, Moldwin RM. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. BJU Int 2012; 109 (09) 1356-1359
    CrossrefPubMedGoogle Scholar
  • 111 Braunstein R, Shapiro E, Kaye J, Moldwin R. The role of cystoscopy in the diagnosis of Hunner's ulcer disease. J Urol 2008; 180 (04) 1383-1386
    CrossrefPubMedGoogle Scholar
  • 112 Parsons CL. How does interstitial cystitis begin?. Transl Androl Urol 2015; 4 (06) 605-610
    PubMedGoogle Scholar
  • 113 Griffith JW, Stephens-Shields AJ, Hou X. , et al. Pain and urinary symptoms should not be combined into a single score: psychometric findings from the MAPP research network. J Urol 2016; 195 (4, Pt 1): 949-954
    CrossrefPubMedGoogle Scholar
  • 114 Forrest JB, Vo Q. Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology 2001; 57 (6, Suppl 1): 26-29
    CrossrefPubMedGoogle Scholar
  • 115 Bosch PC, Bosch DC. Treating interstitial cystitis/bladder pain syndrome as a chronic disease. Rev Urol 2014; 16 (02) 83-87
    PubMedGoogle Scholar
  • 116 Nordling J, Anjum FH, Bade JJ. , et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol 2004; 45 (05) 662-669
    CrossrefPubMedGoogle Scholar
  • 117 Rodríguez MAB, Afari N, Buchwald DS. ; National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Urological Chronic Pelvic Pain. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol 2009; 182 (05) 2123-2131
    CrossrefPubMedGoogle Scholar
  • 118 Birder LA, Hanna-Mitchell AT, Mayer E, Buffington CA. Cystitis, co-morbid disorders and associated epithelial dysfunction. Neurourol Urodyn 2011; 30 (05) 668-672
    CrossrefPubMedGoogle Scholar
  • 119 Nastaskin I, Mehdikhani E, Conklin J, Park S, Pimentel M. Studying the overlap between IBS and GERD: a systematic review of the literature. Dig Dis Sci 2006; 51 (12) 2113-2120
    CrossrefPubMedGoogle Scholar
  • 120 Krieger JN, Stephens AJ, Landis JR. , et al; MAPP Research Network. Relationship between chronic nonurological associated somatic syndromes and symptom severity in urological chronic pelvic pain syndromes: baseline evaluation of the MAPP study. J Urol 2015; 193 (04) 1254-1262
    CrossrefPubMedGoogle Scholar
  • 121 Nickel JC, Tripp DA. ; International Interstitial Cystitis Study Group. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome. J Urol 2015; 193 (01) 138-144
    CrossrefPubMedGoogle Scholar
  • 122 Clemens JQ, Clauw DJ, Kreder K. , et al; MAPP Research Network. Comparison of baseline urological symptoms in men and women in the MAPP research cohort. J Urol 2015; 193 (05) 1554-1558
    CrossrefPubMedGoogle Scholar
  • 123 Warren JW, Clauw DJ, Wesselmann U, Howard FM, Gallicchio L, Morozov V. Functional somatic syndromes as risk factors for hysterectomy in early bladder pain syndrome/interstitial cystitis. J Psychosom Res 2014; 77 (05) 363-367
    CrossrefPubMedGoogle Scholar
  • 124 North CS, Downs D, Clouse RE. , et al. The presentation of irritable bowel syndrome in the context of somatization disorder. Clin Gastroenterol Hepatol 2004; 2 (09) 787-795
    CrossrefPubMedGoogle Scholar
  • 125 Sayuk GS, Elwing JE, Lustman PJ, Clouse RE. Predictors of premature antidepressant discontinuation in functional gastrointestinal disorders. Psychosom Med 2007; 69 (02) 173-181
    CrossrefPubMedGoogle Scholar
  • 126 O'Leary MP, Sant GR, Fowler Jr FJ, Whitmore KE, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology 1997; 49 (5A, Suppl): 58-63
    CrossrefPubMedGoogle Scholar
  • 127 Chaiken DC, Blaivas JG, Blaivas ST. Behavioral therapy for the treatment of refractory interstitial cystitis. J Urol 1993; 149 (06) 1445-1448
    CrossrefPubMedGoogle Scholar
  • 128 Christofi N, Hextall A. An evidence-based approach to lifestyle interventions in urogynaecology. Menopause Int 2007; 13 (04) 154-158
    CrossrefPubMedGoogle Scholar
  • 129 Parsons CL, Koprowski PF. Interstitial cystitis: successful management by increasing urinary voiding intervals. Urology 1991; 37 (03) 207-212
    CrossrefPubMedGoogle Scholar
  • 130 FitzGerald MP, Payne CK, Lukacz ES. , et al; Interstitial Cystitis Collaborative Research Network. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol 2012; 187 (06) 2113-2118
    CrossrefPubMedGoogle Scholar
  • 131 Moldwin RM, Fariello JY. Myofascial trigger points of the pelvic floor: associations with urological pain syndromes and treatment strategies including injection therapy. Curr Urol Rep 2013; 14 (05) 409-417
    CrossrefPubMedGoogle Scholar
  • 132 Weiss JM. Pelvic floor myofascial trigger points: manual therapy for interstitial cystitis and the urgency-frequency syndrome. J Urol 2001; 166 (06) 2226-2231
    CrossrefPubMedGoogle Scholar
  • 133 Whitmore KE. Self-care regimens for patients with interstitial cystitis. Urol Clin North Am 1994; 21 (01) 121-130
    PubMedGoogle Scholar
  • 134 Webster DC, Brennan T. Use and effectiveness of physical self-care strategies for interstitial cystitis. Nurse Pract 1994; 19 (10) 55-61
    PubMedGoogle Scholar
  • 135 Fall M, Baranowski AP, Elneil S. , et al; European Association of Urology. EAU guidelines on chronic pelvic pain. Eur Urol 2010; 57 (01) 35-48
    CrossrefPubMedGoogle Scholar
  • 136 Generali JA, Cada DJ. Amitriptyline: interstitial cystitis (painful bladder syndrome). Hosp Pharm 2014; 49 (09) 809-810
    CrossrefPubMedGoogle Scholar
  • 137 Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?. Eur Urol 2008; 54 (01) 65-75
    CrossrefPubMedGoogle Scholar
  • 138 Theoharides TC. Hydroxyzine in the treatment of interstitial cystitis. Urol Clin North Am 1994; 21 (01) 113-119
    PubMedGoogle Scholar
  • 139 Theoharides TC, Sant GR. Hydroxyzine therapy for interstitial cystitis. Urology 1997; 49 (5A, Suppl): 108-110
    PubMedGoogle Scholar
  • 140 Sant GR, Propert KJ, Hanno PM. , et al; Interstitial Cystitis Clinical Trials Group. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003; 170 (03) 810-815
    CrossrefPubMedGoogle Scholar
  • 141 Thilagarajah R, Witherow RO, Walker MM. Oral cimetidine gives effective symptom relief in painful bladder disease: a prospective, randomized, double-blind placebo-controlled trial. BJU Int 2001; 87 (03) 207-212
    CrossrefPubMedGoogle Scholar
  • 142 Mulholland SG, Sant GR, Hanno P, Staskin DR, Parsons L. Pentosan polysulfate sodium for therapy of interstitial cystitis. Urology 1990; 35 (06) 552-558
    CrossrefPubMedGoogle Scholar
  • 143 Parsons CL, Mulholland SG. Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 1987; 138 (03) 513-516
    CrossrefPubMedGoogle Scholar
  • 144 Fritjofsson A, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol 1987; 138 (03) 508-512
    CrossrefPubMedGoogle Scholar
  • 145 Anderson VR, Perry CM. Pentosan polysulfate: a review of its use in the relief of bladder pain or discomfort in interstitial cystitis. Drugs 2006; 66 (06) 821-835
    CrossrefPubMedGoogle Scholar
  • 146 Colaco M, Evans R. Current guidelines in the management of interstitial cystitis. Transl Androl Urol 2015; 4 (06) 677-683
    PubMedGoogle Scholar
  • 147 Holm-Bentzen M, Jacobsen F, Nerstrøm B. , et al. A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 1987; 138 (03) 503-507
    CrossrefPubMedGoogle Scholar
  • 148 Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Database Syst Rev 2007; ;(04) CD006113
    PubMedGoogle Scholar
  • 149 Ens G, Garrido GL. Role of cystoscopy and hydrodistention in the diagnosis of interstitial cystitis/bladder pain syndrome. Transl Androl Urol 2015; 4 (06) 624-628
    PubMedGoogle Scholar
  • 150 Perez-Marrero R, Emerson LE, Feltis JT. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol 1988; 140 (01) 36-39
    CrossrefPubMedGoogle Scholar
  • 151 Parkin J, Shea C, Sant GR. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach. Urology 1997; 49 (5A, Suppl): 105-107
    CrossrefPubMedGoogle Scholar
  • 152 Peeker R, Haghsheno MA, Holmäng S, Fall M. Intravesical bacillus Calmette-Guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol 2000; 164 (06) 1912-1915 , discussion 1915–1916
    CrossrefPubMedGoogle Scholar
  • 153 Tutolo M, Ammirati E, Castagna G. , et al. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis. Int Braz J Urol 2017; 43 (01) 134-141
    CrossrefPubMedGoogle Scholar
  • 154 Hohlbrugger G, Lentsch P. Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur Urol 1985; 11 (02) 127-130
    CrossrefPubMedGoogle Scholar
  • 155 Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009; 103 (07) 910-918
    CrossrefPubMedGoogle Scholar
  • 156 Henry RA, Morales A, Cahill CM. Beyond a simple anesthetic effect: lidocaine in the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Urology 2015; 85 (05) 1025-1033
    CrossrefPubMedGoogle Scholar
  • 157 Generali JA, Cada DJ. Intravesical heparin: interstitial cystitis (painful bladder syndrome). Hosp Pharm 2013; 48 (10) 822-824
    CrossrefPubMedGoogle Scholar
  • 158 Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005; 65 (01) 45-48
    CrossrefPubMedGoogle Scholar
  • 159 Akiyama Y, Nomiya A, Niimi A. , et al. Botulinum toxin type A injection for refractory interstitial cystitis: a randomized comparative study and predictors of treatment response. Int J Urol 2015; 22 (09) 835-841
    CrossrefPubMedGoogle Scholar
  • 160 Guo C, Yang B, Gu W. , et al. Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis. PLoS One 2013; 8 (12) e82591
    CrossrefPubMedGoogle Scholar
  • 161 Edwards L, Bucknall TE, Makin C. Interstitial cystitis: possible cause and clinical study of sodium cromoglycate. Br J Urol 1986; 58 (01) 95-96
    CrossrefPubMedGoogle Scholar
  • 162 Ahmad I, Sarath Krishna N, Meddings RN. Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19 (04) 543-546
    CrossrefPubMedGoogle Scholar
  • 163 Platte RO, Parekh M, Minassian VA, Poplawsky D. Spontaneous bladder rupture following cystoscopy with hydrodistention and biopsy in a female patient with interstitial cystitis. Female Pelvic Med Reconstr Surg 2011; 17 (03) 149-152
    CrossrefPubMedGoogle Scholar
  • 164 Higson RH, Smith JC, Whelan P. Bladder rupture: an acceptable complication of distension therapy?. Br J Urol 1978; 50 (07) 529-534
    CrossrefPubMedGoogle Scholar
  • 165 Erickson DR, Kunselman AR, Bentley CM. , et al. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol 2007; 177 (02) 556-560
    PubMedGoogle Scholar
  • 166 Turner KJ, Stewart LH. How do you stretch a bladder? A survey of UK practice, a literature review, and a recommendation of a standard approach. Neurourol Urodyn 2005; 24 (01) 74-76
    CrossrefPubMedGoogle Scholar
  • 167 Niimi A, Nomiya A, Yamada Y. , et al. Hydrodistension with or without fulguration of Hunner lesions for interstitial cystitis: long-term outcomes and prognostic predictors. Neurourol Urodyn 2016; 35 (08) 965-969
    CrossrefPubMedGoogle Scholar
  • 168 Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 2000; 11 (05) 290-295
    CrossrefPubMedGoogle Scholar
  • 169 Hillelsohn JH, Rais-Bahrami S, Friedlander JI. , et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol 2012; 188 (06) 2238-2241
    CrossrefPubMedGoogle Scholar
  • 170 Rofeim O, Hom D, Freid RM, Moldwin RM. Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol 2001; 166 (01) 134-136
    CrossrefPubMedGoogle Scholar
  • 171 Lam KH, Yao G, Jin R. Diverse binding modes, same goal: the receptor recognition mechanism of botulinum neurotoxin. Prog Biophys Mol Biol 2015; 117 (2-3) 225-231
    CrossrefPubMedGoogle Scholar
  • 172 Chiu B, Tai HC, Chung SD, Birder LA. Botulinum toxin A for bladder pain syndrome/interstitial cystitis. Toxins (Basel) 2016; 8 (07) E201
    CrossrefPubMedGoogle Scholar
  • 173 Kuo HC, Chancellor MB. Comparison of intravesical botulinum toxin type A injections plus hydrodistention with hydrodistention alone for the treatment of refractory interstitial cystitis/painful bladder syndrome. BJU Int 2009; 104 (05) 657-661
    CrossrefPubMedGoogle Scholar
  • 174 Kuo HC. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis. Urol Int 2005; 75 (02) 170-174
    CrossrefPubMedGoogle Scholar
  • 175 Whitmore KE, Payne CK, Diokno AC, Lukban JC. Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14 (05) 305-308 , discussion 308–309
    CrossrefPubMedGoogle Scholar
  • 176 Maher CF, Carey MP, Dwyer PL, Schluter PL. Percutaneous sacral nerve root neuromodulation for intractable interstitial cystitis. J Urol 2001; 165 (03) 884-886
    CrossrefPubMedGoogle Scholar
  • 177 Comiter CV. Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003; 169 (04) 1369-1373
    CrossrefPubMedGoogle Scholar
  • 178 Peters KM, Konstandt D. Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 2004; 93 (06) 777-779
    CrossrefPubMedGoogle Scholar
  • 179 Gajewski JB, Al-Zahrani AA. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre. BJU Int 2011; 107 (08) 1258-1264
    CrossrefPubMedGoogle Scholar
  • 180 Powell CR, Kreder KJ. Long-term outcomes of urgency-frequency syndrome due to painful bladder syndrome treated with sacral neuromodulation and analysis of failures. J Urol 2010; 183 (01) 173-176
    CrossrefPubMedGoogle Scholar
  • 181 Wang J, Chen Y, Chen J, Zhang G, Wu P. Sacral neuromodulation for refractory bladder pain syndrome/interstitial cystitis: a global systematic review and meta-analysis. Sci Rep 2017; 7 (01) 11031
    CrossrefPubMedGoogle Scholar
  • 182 Sairanen J, Tammela TLJ, Leppilahti M. , et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2005; 174 (06) 2235-2238
    CrossrefPubMedGoogle Scholar
  • 183 Ehrén I, Hallén Grufman K, Vrba M, Sundelin R, Lafolie P. Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C. Scand J Urol 2013; 47 (06) 503-508
    PubMedGoogle Scholar
  • 184 Chade J, Chade D, Lucon AM, Bruschini H, Srougi M. 462 5-year follow-up of patients with refractory interstitial cystitis treated with cyclosporine A: a prospective single-institution study. Eur Urol Suppl 2014; 13 (01) e462
    CrossrefPubMedGoogle Scholar
  • 185 Forsell T, Ruutu M, Isoniemi H, Ahonen J, Alfthan O. Cyclosporine in severe interstitial cystitis. J Urol 1996; 155 (05) 1591-1593
    CrossrefPubMedGoogle Scholar
  • 186 Crescenze IM, Tucky B, Li J, Moore C, Shoskes DA. Efficacy, side effects, and monitoring of oral cyclosporine in interstitial cystitis-bladder pain syndrome. Urology 2017; 107: 49-54
    CrossrefPubMedGoogle Scholar
  • 187 Forrest JB, Payne CK, Erickson DR. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol 2012; 188 (04) 1186-1191
    CrossrefPubMedGoogle Scholar
  • 188 Wang Z, Zhang L. Treatment effect of cyclosporine A in patients with painful bladder syndrome/interstitial cystitis: a systematic review. Exp Ther Med 2016; 12 (01) 445-450
    CrossrefPubMedGoogle Scholar
  • 189 Andersen AV, Granlund P, Schultz A, Talseth T, Hedlund H, Frich L. Long-term experience with surgical treatment of selected patients with bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol 2012; 46 (04) 284-289
    CrossrefPubMedGoogle Scholar
  • 190 Rovner E, Propert KJ, Brensinger C. , et al; The Interstitial Cystitis Data Base Study Group. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. Urology 2000; 56 (06) 940-945
    CrossrefPubMedGoogle Scholar
  • 191 Whitmore KE. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol 2002; 4 (Suppl 1): S28-S35
    PubMedGoogle Scholar
  • 192 Katske F, Shoskes DA, Sender M, Poliakin R, Gagliano K, Rajfer J. Treatment of interstitial cystitis with a quercetin supplement. Tech Urol 2001; 7 (01) 44-46
    PubMedGoogle Scholar
  • 193 Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int J Urol 2009; 16 (01) 4-16
    CrossrefPubMedGoogle Scholar
  • 194 Abrams P, Cardozo L, Fall M. , et al; Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61 (01) 37-49
    CrossrefPubMedGoogle Scholar